MX2010004803A - Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas. - Google Patents
Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas.Info
- Publication number
- MX2010004803A MX2010004803A MX2010004803A MX2010004803A MX2010004803A MX 2010004803 A MX2010004803 A MX 2010004803A MX 2010004803 A MX2010004803 A MX 2010004803A MX 2010004803 A MX2010004803 A MX 2010004803A MX 2010004803 A MX2010004803 A MX 2010004803A
- Authority
- MX
- Mexico
- Prior art keywords
- therapeutics
- small molecule
- new class
- molecule diffusion
- enhance small
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
La presente solicitud se refiere a composiciones novedosas que contienen un compuesto que mejora la difusión y su uso en el tratamiento de una variedad de trastornos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US109507P | 2007-10-31 | 2007-10-31 | |
PCT/US2008/012440 WO2009058399A1 (en) | 2007-10-31 | 2008-10-31 | A new class of therapeutics that enhance small molecule diffusion |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004803A true MX2010004803A (es) | 2010-09-09 |
Family
ID=40583148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004803A MX2010004803A (es) | 2007-10-31 | 2008-10-31 | Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas. |
Country Status (13)
Country | Link |
---|---|
US (2) | US8206751B2 (es) |
EP (1) | EP2214714A4 (es) |
JP (2) | JP2011502125A (es) |
KR (1) | KR20100083820A (es) |
CN (1) | CN101878040A (es) |
AU (1) | AU2008319225B2 (es) |
BR (1) | BRPI0818119A2 (es) |
CA (1) | CA2703946A1 (es) |
EA (1) | EA201070544A1 (es) |
IL (1) | IL205417A0 (es) |
MX (1) | MX2010004803A (es) |
WO (1) | WO2009058399A1 (es) |
ZA (1) | ZA201003475B (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
IL163685A0 (en) * | 2002-02-25 | 2005-12-18 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
CA2598882C (en) * | 2005-02-24 | 2020-02-25 | Diffusion Pharmaceuticals Llc | Trans carotenoids, their synthesis, formulation and uses |
EP2198869B1 (en) * | 2007-02-23 | 2015-09-16 | Next 21 K.K. | Trehalose for the treatment or prevention of vasospasm |
KR101570131B1 (ko) | 2007-04-13 | 2015-11-18 | 디퓨젼 파마슈티컬즈 엘엘씨 | 양극성 트랜스 카로티노이드의 말초혈관질환 치료와 예방을 위한 용도 |
EA201070544A1 (ru) | 2007-10-31 | 2010-12-30 | Диффьюжн Фармасьютикалз Ллс | Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений |
JP6076597B2 (ja) | 2008-08-09 | 2017-02-08 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | 化粧品としてのインドール化合物の使用 |
CN108464976A (zh) | 2009-06-22 | 2018-08-31 | 扩散药品有限公司 | 扩散促进化合物及其单独或与溶栓药一起的应用 |
US8974822B2 (en) | 2010-06-02 | 2015-03-10 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
CN102372623A (zh) * | 2010-08-27 | 2012-03-14 | 江苏天晟药业有限公司 | 藏红花酸二铵盐 |
US20130323166A1 (en) * | 2010-09-10 | 2013-12-05 | William Beaumont Hospital | Radiation Therapy for Treating Alzheimer's Disease |
US20120171184A1 (en) * | 2010-12-31 | 2012-07-05 | Lajos Szente | Cellular hydration compositions |
BR112013016809A2 (pt) | 2010-12-31 | 2016-09-27 | Eastpond Lab Ltd | composições de hidratação celular |
CN102210868A (zh) * | 2011-04-29 | 2011-10-12 | 济南环肽医药科技有限公司 | 四氢嘧啶及其衍生物在制备口服吸收促进剂中的应用 |
CN102210685B (zh) * | 2011-04-29 | 2013-01-30 | 济南环肽医药科技有限公司 | 四氢嘧啶及其衍生物在制备预防和治疗化疗药物引发的口腔粘膜炎药物中的应用 |
CN102210869B (zh) * | 2011-04-29 | 2012-07-25 | 山东弘立医学动物实验研究有限公司 | 四氢嘧啶及其衍生物在制备透皮吸收促进剂中的应用 |
CN102274238B (zh) * | 2011-06-30 | 2012-10-03 | 山东弘立医学动物实验研究有限公司 | 一种治疗胰腺癌的药物组合物 |
CN102847161A (zh) * | 2011-06-30 | 2013-01-02 | 山东弘立医学动物实验研究有限公司 | 四氢嘧啶及其衍生物在制备药物肺部收促进剂中的应用 |
CN102302498B (zh) * | 2011-08-22 | 2012-10-03 | 济南环肽医药科技有限公司 | 一种治疗肾炎的药物 |
GB201120772D0 (en) * | 2011-12-02 | 2012-01-11 | Ip Science Ltd | Cocoa-based food products |
US9084720B2 (en) | 2013-05-07 | 2015-07-21 | BioBlast Pharma Ltd. | Compositions and methods for treating oculopharyngeal muscular dystrophy |
JP6837835B2 (ja) * | 2013-05-07 | 2021-03-03 | バイオ・ブラスト・ファーマ・リミテッドBio Blast Pharma Ltd. | トレハロースの非経口投与によるタンパク質凝集ミオパシーおよび神経変性疾患の治療 |
US20150345882A1 (en) * | 2014-06-03 | 2015-12-03 | Magpul Industries Corp | Compact anti-tilt follower for an ammunition magazine |
CN104069110A (zh) * | 2014-07-14 | 2014-10-01 | 济南环肽医药科技有限公司 | 四氢嘧啶及其衍生物在制备血容量扩充药物中的应用 |
KR102489034B1 (ko) * | 2016-03-24 | 2023-01-13 | 디퓨젼 파마슈티컬즈 엘엘씨 | 암을 치료하기 위한, 화학 요법 및 방사선 요법과의 양극성 트랜스 카로티노이드의 용도 |
AU2018241520A1 (en) | 2017-03-31 | 2019-10-24 | The Florey Institute Of Neuroscience And Mental Health | Prophylaxis and treatment of cognitive dysfunction and decline |
JP2017155046A (ja) * | 2017-04-05 | 2017-09-07 | イーストポンド・ラボラトリーズ・リミテッド | シクロデキストリンを含有する細胞水和組成物 |
NZ764440A (en) | 2017-11-16 | 2024-03-22 | Aivita Biomedical Inc | Use of cell membrane-bound signaling factors |
JP2019178154A (ja) * | 2019-06-18 | 2019-10-17 | イーストポンド・ラボラトリーズ・リミテッド | シクロデキストリンを含有する細胞水和組成物 |
WO2021205237A1 (en) | 2020-04-06 | 2021-10-14 | Eastpond Laboratories Limited | Compositions for promoting cellular hydration |
KR102453320B1 (ko) | 2022-04-29 | 2022-10-11 | 장세진 | 유속 증가 기능을 갖는 수류터빈 및 이를 활용한 수류발전 시스템 |
WO2024006901A1 (en) * | 2022-06-29 | 2024-01-04 | Diffusion Pharmaceuticals Llc | Uses of bipolar trans carotenoids in the treatment of cancer |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2948748A (en) * | 1960-08-09 | Esters thereof | ||
US2175843A (en) * | 1936-06-26 | 1939-10-10 | Winthrop Chem Co Inc | Polyene carboxylic acids and esters and manufacture thereof |
US2175853A (en) * | 1937-12-28 | 1939-10-10 | Ross John Fisher | Washing machine |
US2948843A (en) * | 1959-08-28 | 1960-08-09 | Gen Electric | Voltage limiter |
CH468330A (de) * | 1966-01-28 | 1969-02-15 | Hoffmann La Roche | Verfahren zur Herstellung von isoprenoiden Verbindungen |
US3489806A (en) * | 1967-01-19 | 1970-01-13 | Hoffmann La Roche | Isoprenoid compounds and a process for producing the same |
CH522572A (de) | 1969-10-31 | 1972-06-30 | Hoffmann La Roche | Verfahren zur Herstellung von Polyenverbindungen |
US3853993A (en) * | 1973-05-01 | 1974-12-10 | Univ Virginia | Process for increasing oxygen diffusivity and method for treating atherosclerosis |
US3788468A (en) * | 1973-05-01 | 1974-01-29 | Univ Virginia | Process for increasing oxygen diffusivity |
DE2505869C3 (de) * | 1975-02-12 | 1978-05-18 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von symmetrischen Carotinoiden |
US3965261A (en) * | 1975-04-29 | 1976-06-22 | University Of Virginia | Method for treating papillomas |
US3975519A (en) * | 1975-06-09 | 1976-08-17 | University Of Virginia | Method for increasing the oxygen partial pressure in the bloodstream of mammals |
US4070460A (en) * | 1975-11-10 | 1978-01-24 | University Of Virginia Patents Foundation | Method for treating cerebral edema |
US4009270A (en) * | 1975-11-21 | 1977-02-22 | The University Of Virginia | Method for treating spinal cord injury |
US4038144A (en) * | 1976-04-19 | 1977-07-26 | The University Of Virginia | Method of increasing fermentation yields |
US4046880A (en) * | 1976-04-20 | 1977-09-06 | The University Of Virginia | Method of treating hypertension |
US4099270A (en) | 1977-02-16 | 1978-07-11 | Jabour Richard J | Slip-on rubber gloves |
US4216211A (en) * | 1977-10-31 | 1980-08-05 | The Procter & Gamble Company | Therapeutic composition |
US4176179A (en) * | 1978-04-17 | 1979-11-27 | The University Of Virginia Alumni Patents Foundation | Method for treating arthritis |
US4699664A (en) | 1985-05-01 | 1987-10-13 | Nestec S.A. | Stabilized natural pigment complexes |
US5032613A (en) * | 1986-02-12 | 1991-07-16 | W. Keith R. Watson | Method and composition for treating arthritis |
JPH0661211B2 (ja) | 1986-08-29 | 1994-08-17 | 花王株式会社 | パン用改質剤、パン生地及びパンの製造方法 |
US5811119A (en) * | 1987-05-19 | 1998-09-22 | Board Of Regents, The University Of Texas | Formulation and use of carotenoids in treatment of cancer |
US5472946A (en) * | 1988-04-08 | 1995-12-05 | Peck; James V. | Transdermal penetration enhancers |
FR2647343B1 (fr) | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | Nouvelle forme pharmaceutique poreuse et sa preparation |
IT1233303B (it) | 1989-06-07 | 1992-03-26 | Azionaria Costruzioni Acma Spa | Apparecchiatura per il convogliamento di prodotti |
US5053240A (en) * | 1989-10-24 | 1991-10-01 | Kalamazoo Holdings, Inc. | Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides |
JPH04264020A (ja) | 1991-02-18 | 1992-09-18 | Yamanouchi Pharmaceut Co Ltd | 安定な凍結乾燥製剤 |
US5107030A (en) | 1991-03-04 | 1992-04-21 | Loyola University Of Chicago | Method of making 2,7-dimethyl-2,4,6-octatrienedial and derivatives thereof |
JP3176716B2 (ja) | 1991-06-21 | 2001-06-18 | 武田薬品工業株式会社 | 溶解性が向上した難水溶性薬物組成物 |
JP2977961B2 (ja) | 1991-07-26 | 1999-11-15 | 株式会社資生堂 | 化粧料 |
JPH06248193A (ja) * | 1993-02-25 | 1994-09-06 | Ensuiko Sugar Refining Co Ltd | クロセチン含有着色料 |
IL110139A0 (en) | 1993-06-28 | 1994-10-07 | Howard Foundation | Pharmaceutically-active antioxidants |
JPH0723736A (ja) | 1993-06-30 | 1995-01-27 | Taishiyoo Technos:Kk | カロチノイド色素の可溶化方法 |
JP2704356B2 (ja) | 1994-02-08 | 1998-01-26 | 正和薬品株式会社 | 脳機能改善剤 |
JPH07291854A (ja) | 1994-04-26 | 1995-11-07 | Tanabe Seiyaku Co Ltd | 溶解性の改善された医薬品製剤 |
US5576287A (en) * | 1994-04-29 | 1996-11-19 | Wake Forest University | Method for treating acute renal disease and failure |
GB2290964A (en) * | 1994-07-08 | 1996-01-17 | Arto Olavi Urtti | Transdermal drug delivery system |
US6060511A (en) * | 1995-10-05 | 2000-05-09 | Gainer; John L. | Trans-sodium crocetinate, methods of making and methods of use thereof |
US5800807A (en) * | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
JPH1129466A (ja) * | 1997-07-09 | 1999-02-02 | Lion Corp | 水性皮膚外用剤 |
US6391336B1 (en) | 1997-09-22 | 2002-05-21 | Royer Biomedical, Inc. | Inorganic-polymer complexes for the controlled release of compounds including medicinals |
US6150561A (en) | 1997-10-03 | 2000-11-21 | Roche Vitamins Inc. | Method of making carotenoids |
JPH11209642A (ja) | 1998-01-27 | 1999-08-03 | Taito Kk | アナトー色素製剤及びその製造方法 |
JP2000007570A (ja) * | 1998-06-24 | 2000-01-11 | Hayashibara Biochem Lab Inc | 抗内分泌障害剤 |
MA25590A1 (fr) | 1998-09-14 | 2002-12-31 | Inhale Therapeutic Syst | Agent actif de delivraison de poudre seche |
BE1012495A3 (fr) * | 1999-03-02 | 2000-11-07 | Messadek Jallal | La glycine-betaine pour son usage antithrombotique. |
JP2001051135A (ja) * | 1999-08-06 | 2001-02-23 | Hitachi Cable Ltd | 光波長合分波器 |
GB2353934A (en) * | 1999-09-09 | 2001-03-14 | British Sugar Plc | Nutritional compositions comprising trehalose for persons suffering from diabetes |
JP2001302517A (ja) * | 2000-04-24 | 2001-10-31 | Tokyo Univ Of Pharmacy & Life Science | 脳浮腫の予防治療薬 |
CA2355814C (en) * | 2000-09-14 | 2010-06-29 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Pharmaceutical composition for ophthalmic use |
BE1015608A6 (fr) * | 2003-07-15 | 2005-06-07 | Messadek Jallal | Traitement des arterites. |
US7759506B2 (en) * | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
IL163685A0 (en) | 2002-02-25 | 2005-12-18 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
US20030180282A1 (en) * | 2002-03-25 | 2003-09-25 | Victor Serebruany | Method of treatment of thrombotic events |
AU2003256982A1 (en) * | 2002-07-29 | 2004-02-16 | Cardax Pharmaceuticals, Inc. | Structural carotenoid analogs for the inhibition and amelioration of disease |
DE10254809A1 (de) | 2002-11-22 | 2004-06-03 | Basf Ag | Verfahren zur Herstellung von Carotinoiden |
AU2002343174A1 (en) * | 2002-11-25 | 2004-06-18 | Rachid Ennamany | Betaine and salicylic acid compositions |
US20040109920A1 (en) * | 2002-12-04 | 2004-06-10 | Bioactives Llc | Coated carotenoid cyclodextrin complexes |
US20070166339A1 (en) * | 2003-04-18 | 2007-07-19 | Bioderm Research | Skin Whitening Methods and Compositions Based on Zeolite - Active Oxygen Donor Complexes |
JP2005053841A (ja) * | 2003-08-05 | 2005-03-03 | Kyouto Biomedical Science:Kk | 皮膚外用剤 |
AU2003265617A1 (en) | 2003-08-25 | 2005-04-11 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
US7446101B1 (en) * | 2003-12-12 | 2008-11-04 | Bioactives, Llc | Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems |
RU2007101074A (ru) * | 2004-06-14 | 2008-07-20 | Зозер Б. САЛАМА (DE) | Фармацевтическая противораковая композиция пролина или его производных и противоопухолевого антитела |
JP4514114B2 (ja) | 2004-06-18 | 2010-07-28 | ヤマハ発動機株式会社 | コイル可動形リニアモータおよび単軸ロボット |
CA2581764A1 (en) * | 2004-09-27 | 2006-04-06 | Sigmoid Biotechnologies Limited | Minicapsule formulations |
US7247752B2 (en) | 2004-10-01 | 2007-07-24 | Cardax Pharmaceuticals, Inc. | Methods for the synthesis of astaxanthin |
CA2598882C (en) * | 2005-02-24 | 2020-02-25 | Diffusion Pharmaceuticals Llc | Trans carotenoids, their synthesis, formulation and uses |
US20090176287A1 (en) * | 2005-02-24 | 2009-07-09 | Regents Of The University Of Minnesota | Producing carotenoids |
EP1861109A2 (en) * | 2005-03-09 | 2007-12-05 | Cardax Pharmaceuticals, Inc. | Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders |
PT1874825E (pt) * | 2005-04-26 | 2010-06-22 | Sandoz Ag | Ligandos de afinidade |
JP2006342108A (ja) * | 2005-06-09 | 2006-12-21 | Mitsubishi Chemicals Corp | アミロスフェロイドにより発生する疾患の予防治療剤 |
WO2007028167A2 (en) * | 2005-09-02 | 2007-03-08 | Iomai Corporation | Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs and uses thereof |
ITMI20052486A1 (it) | 2005-12-23 | 2007-06-24 | Italiana Sint Spa | Procedimento di sintesi di intermedi per la preparazione di astaxantina |
AU2006341188A1 (en) * | 2006-03-24 | 2007-10-04 | Ian Simon Tracton | Stable packaged dosage form and process therefor |
CN100571707C (zh) * | 2006-07-24 | 2009-12-23 | 凌沛学 | 含有海藻糖的关节腔内注射给药制剂 |
EP2198869B1 (en) * | 2007-02-23 | 2015-09-16 | Next 21 K.K. | Trehalose for the treatment or prevention of vasospasm |
KR101570131B1 (ko) * | 2007-04-13 | 2015-11-18 | 디퓨젼 파마슈티컬즈 엘엘씨 | 양극성 트랜스 카로티노이드의 말초혈관질환 치료와 예방을 위한 용도 |
EA201070544A1 (ru) | 2007-10-31 | 2010-12-30 | Диффьюжн Фармасьютикалз Ллс | Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений |
-
2008
- 2008-10-31 EA EA201070544A patent/EA201070544A1/ru unknown
- 2008-10-31 KR KR1020107010445A patent/KR20100083820A/ko active IP Right Grant
- 2008-10-31 CN CN2008801143109A patent/CN101878040A/zh active Pending
- 2008-10-31 CA CA2703946A patent/CA2703946A1/en not_active Abandoned
- 2008-10-31 AU AU2008319225A patent/AU2008319225B2/en not_active Expired - Fee Related
- 2008-10-31 WO PCT/US2008/012440 patent/WO2009058399A1/en active Application Filing
- 2008-10-31 EP EP08844993A patent/EP2214714A4/en not_active Withdrawn
- 2008-10-31 JP JP2010531078A patent/JP2011502125A/ja not_active Ceased
- 2008-10-31 US US12/289,713 patent/US8206751B2/en active Active
- 2008-10-31 MX MX2010004803A patent/MX2010004803A/es not_active Application Discontinuation
- 2008-10-31 BR BRPI0818119-5A patent/BRPI0818119A2/pt not_active IP Right Cessation
-
2010
- 2010-04-28 IL IL205417A patent/IL205417A0/en unknown
- 2010-05-17 ZA ZA2010/03475A patent/ZA201003475B/en unknown
-
2012
- 2012-06-22 US US13/507,365 patent/US20130018014A1/en not_active Abandoned
-
2015
- 2015-08-13 JP JP2015159872A patent/JP2016026156A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IL205417A0 (en) | 2010-12-30 |
JP2011502125A (ja) | 2011-01-20 |
ZA201003475B (en) | 2011-10-26 |
CN101878040A (zh) | 2010-11-03 |
EP2214714A4 (en) | 2011-01-12 |
JP2016026156A (ja) | 2016-02-12 |
US8206751B2 (en) | 2012-06-26 |
CA2703946A1 (en) | 2009-05-07 |
US20130018014A1 (en) | 2013-01-17 |
EA201070544A1 (ru) | 2010-12-30 |
KR20100083820A (ko) | 2010-07-22 |
AU2008319225A1 (en) | 2009-05-07 |
BRPI0818119A2 (pt) | 2015-08-04 |
US20090110746A1 (en) | 2009-04-30 |
AU2008319225B2 (en) | 2016-09-29 |
WO2009058399A1 (en) | 2009-05-07 |
EP2214714A1 (en) | 2010-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010004803A (es) | Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas. | |
TW200637490A (en) | Fertilizer-compatible composition | |
MX2010007867A (es) | Composiciones de limpieza personal concentradas. | |
MX2011004236A (es) | Composiciones concentradas para tratamiento de superficies duras. | |
MX2010004126A (es) | Composiciones para el cuidado personal que comprenden undecil sulfatos. | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
DE602008000754D1 (de) | Tropanverbindungen | |
MX2010006143A (es) | Azolilmetiloxiranos, su uso y agentes que lo contienen. | |
GB0625648D0 (en) | Compounds | |
GEP20125652B (en) | cMET INHIBITORS | |
TW200618817A (en) | Diffractive colorants for cosmetics | |
MX2007008790A (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso. | |
EA200701995A1 (ru) | Способы уменьшения кальцификации | |
UA98804C2 (ru) | Катехоламиновые производные и фармацевтическая композиция на их основе | |
UA102858C2 (ru) | Производные пиридино-пиридинонов, способ их получения и применения в терапии | |
EA201100921A1 (ru) | Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ | |
EA200701172A1 (ru) | 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение | |
HK1141790A1 (es) | ||
DOP2010000329A (es) | Inhibidores de la renina | |
MX342947B (es) | Tratamiento de diabetes tipo 2. | |
CA2767833C (en) | N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen | |
SG158091A1 (en) | Imidazoazepinone compounds | |
TW200940659A (en) | Azopyridone disperse dyes, their preparation and use | |
ZA201003970B (en) | Shading composition | |
MX2009009345A (es) | Compuestos de pirimidinona fusionados como ligandos de mglur. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |